🟢 Fennec Pharmaceuticals is trading 10.69% up today after second-quarter sales rose 78% year over year

Fennec Pharmaceuticals is trading 10.69% up at $12.11 after reporting strong second-quarter 2026 results before the August 11, 2026 market open.

• Net product sales reached $17.1 million, up 78% year over year.
• Adjusted EBITDA improved to $2.8 million from a $1.2 million loss.
• Record PEDMARK demand and continued commercial expansion supported the upbeat business update.